Imerys (NK) H1 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2024 earnings summary
8 Jul, 2026Executive summary
H1 2024 revenue reached €1,919 million, marking three consecutive quarters of sequential growth, with Q2 volumes up 2.7% year-over-year and strong U.S. demand alongside gradual European recovery.
Adjusted EBITDA for H1 2024 was €384 million, up 11% year-over-year, with a 20% margin (+260 bps), driven by volume recovery, cost savings, and positive price-cost balance.
Net current free cash flow before strategic CapEx was €120 million; net financial debt stable at €1.2 billion, with a net financial debt/adjusted EBITDA ratio of 1.7x.
Completed disposal of paper market assets for ~€150 million in July 2024, streamlining the portfolio and eliminating exposure to graphic paper.
Disclosed a Climate Transition Plan targeting 42% reduction in scope 1 & 2 and 25% in scope 3 GHG emissions by 2030, and renewed a biodiversity partnership.
Financial highlights
H1 2024 sales reached €1.9 billion, with a 7% sequential increase from Q1 and Q2 revenue of €992 million (+0.7% year-over-year, +2.2% like-for-like), entirely volume-driven.
Adjusted EBITDA margin improved to 20% in H1 2024, up from 17.4% in H1 2023, supported by €70 million in cost savings and joint venture contributions.
Current operating income for H1 2024 was €253 million (13.3% of sales); current net income from continuing operations was €173 million, up 25% year-over-year.
Net income, Group share, was €142 million, slightly down year-over-year due to lower discontinued operations.
Net current free operating cash flow was €88 million, with €1.1 billion in cash and €960 million in credit lines as of June 30, 2024.
Outlook and guidance
Expects continued positive business momentum in H2 2024, targeting full-year adjusted EBITDA of €670–690 million, compared to €668 million in 2023, despite the absence of paper business contributions.
Guidance assumes stable macroeconomic conditions and a significantly lower contribution from joint ventures in H2.
Anticipates ongoing recovery in traditional businesses and further improvement in graphite and carbon, while remaining prudent on high purity quartz due to inventory overhang.
Latest events from Imerys
- Solid organic growth, margin expansion, and strong ESG progress despite non-cash net loss.NK
H2 20249 Jul 2026 - All resolutions passed, with strong 2024 results, higher dividend, and strategic progress.NK
AGM 20258 Jul 2026 - All resolutions passed, with stable financials, new board members, and key strategic initiatives advanced.NK
AGM 20268 Jul 2026 - Q1 2026 saw modest growth and margin gains, offset by FX and restructuring impacts.NK
Q1 202629 Apr 2026 - Stable 2025 results, major goodwill impairment, and cost savings plus lithium investment ahead.NK
Q4 202520 Feb 2026 - Nine-month EBITDA margin rose to 19.2% as full-year guidance is confirmed.NK
Q3 202417 Jan 2026 - Organic growth and sustainability progress offset margin pressure from joint venture declines.NK
Q1 202524 Dec 2025 - Stable H1 2025 sales and EBITDA, but net income fell; full-year EBITDA guidance reaffirmed.NK
Q2 202516 Nov 2025 - Revenue down 0.7% YTD; cost controls and strategic growth moves support profitability.NK
Q3 20251 Nov 2025